Literature DB >> 14516446

Chagas' disease diagnosis: comparative analysis of recombinant ELISA with conventional ELISA and the haemagglutination test.

A A M Gadelha1, A F A Verçosa, V M B Lorena, M Nakazawa, A B Carvalho, W V Souza, A G P Ferreira, E D Silva, M A Krieger, S Goldenberg, Y M Gomes.   

Abstract

BACKGROUND AND OBJECTIVES: Serological screening for Chagas' disease in the blood banks of South America is carried out by using two different assays that generally show a high number of inconclusive results. To establish a combination of two tests that can minimize the number of inconclusive results, we compared a recombinant enzyme-linked immunosorbent assay (ELISA) with two conventional tests.
MATERIALS AND METHODS: Serum samples from chagasic patients (n = 112), from non-chagasic individuals (n = 143) and from patients with other diseases (n = 32) were tested using three assays: recombinant ELISA (Rec-ELISA); conventional ELISA (Con-ELISA); and the indirect haemagglutination (IHA) test.
RESULTS: When we evaluated the data by matching the Rec-ELISA and the IHA test, 52 inconclusive results were obtained. When Rec-ELISA and Con-ELISA were matched, only four inconclusive results were observed.
CONCLUSIONS: Our investigation indicates that the use of two ELISAs with different antigen preparations provides an effective test combination for blood bank screening of Chagas' disease. Copyright 2003 Blackwell Publishing

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14516446     DOI: 10.1046/j.1423-0410.2003.00340.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  12 in total

1.  Estimation of sensitivity and specificity of several Trypanosoma cruzi antibody assays in blood donors in Argentina.

Authors:  Mirta C Remesar; Cecilia Gamba; Ivana F Colaianni; Mónica Puppo; Paula A Sartor; Edward L Murphy; Torsten B Neilands; María A Ridolfi; M Susana Leguizamón; Silvina Kuperman; Ana E Del Pozo
Journal:  Transfusion       Date:  2009-11       Impact factor: 3.157

2.  Cellular immune response from Chagasic patients to CRA or FRA recombinant antigens of Trypanosoma cruzi.

Authors:  Virginia M B Lorena; Alinne F A Verçosa; Raquel C A Machado; Lucas Moitinho-Silva; Maria G A Cavalcanti; Edimilson D Silva; Antonio G P Ferreira; Rodrigo Correa-Oliveira; Valéria R A Pereira; Yara M Gomes
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

3.  Chronic Chagas Disease Diagnosis: A Comparative Performance of Commercial Enzyme Immunoassay Tests.

Authors:  Fred Luciano Neves Santos; Wayner Vieira de Souza; Michelle da Silva Barros; Mineo Nakazawa; Marco Aurélio Krieger; Yara de Miranda Gomes
Journal:  Am J Trop Med Hyg       Date:  2016-03-14       Impact factor: 2.345

4.  Performance of six diagnostic tests to screen for Chagas disease in blood banks andprevalence of Trypanosoma cruzi infection among donors with inconclusive serologyscreening based on the analysis of epidemiological variables.

Authors:  Gilberto de Araujo Pereira; Francisco Louzada-Neto; Valdirene de Fátima Barbosa; Márcia Maria Ferreira-Silva; Helio de Moraes-Souza
Journal:  Rev Bras Hematol Hemoter       Date:  2012

5.  Chagas' disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic Chagasic patients.

Authors:  A F A Verçosa; V M B Lorena; C L Carvalho; M F A D Melo; M G A Cavalcanti; E D Silva; A G P Ferreira; V R A Pereira; W V Souza; Y M Gomes
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

Review 6.  ELISA versus PCR for diagnosis of chronic Chagas disease: systematic review and meta-analysis.

Authors:  Pedro E A A Brasil; Liane De Castro; Alejandro M Hasslocher-Moreno; Luiz H C Sangenis; José U Braga
Journal:  BMC Infect Dis       Date:  2010-11-25       Impact factor: 3.090

7.  Accuracy of chimeric proteins in the serological diagnosis of chronic chagas disease - a Phase II study.

Authors:  Fred Luciano Neves Santos; Paola Alejandra Fiorani Celedon; Nilson Ivo Tonin Zanchin; Wayner Vieira de Souza; Edimilson Domingos da Silva; Leonardo Foti; Marco Aurélio Krieger; Yara de Miranda Gomes
Journal:  PLoS Negl Trop Dis       Date:  2017-03-08

8.  Cross-Reactivity Using Chimeric Trypanosoma cruzi Antigens: Diagnostic Performance in Settings Where Chagas Disease and American Cutaneous or Visceral Leishmaniasis Are Coendemic.

Authors:  Ramona Tavares Daltro; Leonardo Maia Leony; Natália Erdens Maron Freitas; Ângelo Antônio Oliveira Silva; Emily Ferreira Santos; Rodrigo Pimenta Del-Rei; Maria Edileuza Felinto Brito; Sinval Pinto Brandão-Filho; Yara Miranda Gomes; Marcelo Sousa Silva; Silvia Tavares Donato; Selma Maria Bezerra Jeronimo; Gloria Regina de Góis Monteiro; Lucas Pedreira Carvalho; Andréa Santos Magalhães; Nilson Ivo Tonin Zanchin; Paola Alejandra Fiorani Celedon; Fred Luciano Neves Santos
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

Review 9.  Commercial enzyme-linked immunosorbent assay versuspolymerase chain reaction for the diagnosis of chronic Chagas disease: a systematic review and meta-analysis.

Authors:  Pedro Emmanuel Alvarenga Americano do Brasil; Rodolfo Castro; Liane de Castro
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-01       Impact factor: 2.743

10.  Performance Assessment of Four Chimeric Trypanosoma cruzi Antigens Based on Antigen-Antibody Detection for Diagnosis of Chronic Chagas Disease.

Authors:  Fred Luciano Neves Santos; Paola Alejandra Fiorani Celedon; Nilson Ivo Tonin Zanchin; Tatiana de Arruda Campos Brasil; Leonardo Foti; Wayner Vieira de Souza; Edmilson Domingos Silva; Yara de Miranda Gomes; Marco Aurélio Krieger
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.